Literature DB >> 21291568

We should not be complacent about our population-based public health response to the first influenza pandemic of the 21st century.

Heath A Kelly1, Patricia C Priest, Geoffry N Mercer, Gary K Dowse.   

Abstract

BACKGROUND: More than a year after an influenza pandemic was declared in June 2009, the World Health Organization declared the pandemic to be over. Evaluations of the pandemic response are beginning to appear in the public domain. DISCUSSION: We argue that, despite the enormous effort made to control the pandemic, it is now time to acknowledge that many of the population-based public health interventions may not have been well considered. Prior to the pandemic, there was limited scientific evidence to support border control measures. In particular no border screening measures would have detected prodromal or asymptomatic infections, and asymptomatic infections with pandemic influenza were common. School closures, when they were partial or of short duration, would not have interrupted spread of the virus in school-aged children, the group with the highest rate of infection worldwide. In most countries where they were available, neuraminidase inhibitors were not distributed quickly enough to have had an effect at the population level, although they will have benefited individuals, and prophylaxis within closed communities will have been effective. A pandemic specific vaccine will have protected the people who received it, although in most countries only a small minority was vaccinated, and often a small minority of those most at risk. The pandemic vaccine was generally not available early enough to have influenced the shape of the first pandemic wave and it is likely that any future pandemic vaccine manufactured using current technology will also be available too late, at least in one hemisphere.
SUMMARY: Border screening, school closure, widespread anti-viral prophylaxis and a pandemic-specific vaccine were unlikely to have been effective during a pandemic which was less severe than anticipated in the pandemic plans of many countries. These were cornerstones of the population-based public health response. Similar responses would be even less likely to be effective in a more severe pandemic. We agree with the recommendation from the World Health Organisation that pandemic preparedness plans need review.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21291568      PMCID: PMC3048535          DOI: 10.1186/1471-2458-11-78

Source DB:  PubMed          Journal:  BMC Public Health        ISSN: 1471-2458            Impact factor:   3.295


  46 in total

1.  Single-dose versus multi-dose vaccine vials for immunization programmes in developing countries.

Authors:  Paul K Drain; Carib M Nelson; John S Lloyd
Journal:  Bull World Health Organ       Date:  2003-11-25       Impact factor: 9.408

Review 2.  Prevention of influenza: recommendations for influenza immunization of children, 2007-2008.

Authors: 
Journal:  Pediatrics       Date:  2008-04       Impact factor: 7.124

3.  Time lines of infection and disease in human influenza: a review of volunteer challenge studies.

Authors:  Fabrice Carrat; Elisabeta Vergu; Neil M Ferguson; Magali Lemaitre; Simon Cauchemez; Steve Leach; Alain-Jacques Valleron
Journal:  Am J Epidemiol       Date:  2008-01-29       Impact factor: 4.897

4.  Estimating the impact of school closure on influenza transmission from Sentinel data.

Authors:  Simon Cauchemez; Alain-Jacques Valleron; Pierre-Yves Boëlle; Antoine Flahault; Neil M Ferguson
Journal:  Nature       Date:  2008-04-10       Impact factor: 49.962

5.  Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study.

Authors:  Marta Valenciano; Esther Kissling; Jean-Marie Cohen; Beatrix Oroszi; Anne-Sophie Barret; Caterina Rizzo; Baltazar Nunes; Daniela Pitigoi; Amparro Larrauri Cámara; Anne Mosnier; Judith K Horvath; Joan O'Donnell; Antonino Bella; Raquel Guiomar; Emilia Lupulescu; Camelia Savulescu; Bruno C Ciancio; Piotr Kramarz; Alain Moren
Journal:  PLoS Med       Date:  2011-01-11       Impact factor: 11.069

6.  Strategies for mitigating an influenza pandemic.

Authors:  Neil M Ferguson; Derek A T Cummings; Christophe Fraser; James C Cajka; Philip C Cooley; Donald S Burke
Journal:  Nature       Date:  2006-04-26       Impact factor: 49.962

7.  Non-pharmaceutical interventions for pandemic influenza, national and community measures.

Authors:  David Bell; Angus Nicoll; Keiji Fukuda; Peter Horby; Arnold Monto; Frederick Hayden; Clare Wylks; Lance Sanders; Jonathan van Tam
Journal:  Emerg Infect Dis       Date:  2006-01       Impact factor: 6.883

8.  Cutaneous infrared thermometry for detecting febrile patients.

Authors:  Pierre Hausfater; Yan Zhao; Stéphanie Defrenne; Pascale Bonnet; Bruno Riou
Journal:  Emerg Infect Dis       Date:  2008-08       Impact factor: 6.883

9.  A biological model for influenza transmission: pandemic planning implications of asymptomatic infection and immunity.

Authors:  John D Mathews; Christopher T McCaw; Jodie McVernon; Emma S McBryde; James M McCaw
Journal:  PLoS One       Date:  2007-11-28       Impact factor: 3.240

10.  Protective effect of maritime quarantine in South Pacific jurisdictions, 1918-19 influenza pandemic.

Authors:  Melissa A McLeod; Michael Baker; Nick Wilson; Heath Kelly; Tom Kiedrzynski; Jacob L Kool
Journal:  Emerg Infect Dis       Date:  2008-03       Impact factor: 6.883

View more
  6 in total

1.  The classical definition of a pandemic is not elusive.

Authors:  Heath Kelly
Journal:  Bull World Health Organ       Date:  2011-07-01       Impact factor: 9.408

2.  Aerosol susceptibility of influenza virus to UV-C light.

Authors:  James J McDevitt; Stephen N Rudnick; Lewis J Radonovich
Journal:  Appl Environ Microbiol       Date:  2012-01-06       Impact factor: 4.792

Review 3.  Are we prepared to help low-resource communities cope with a severe influenza pandemic?

Authors:  Eric S Starbuck; Rudolph von Bernuth; Kathryn Bolles; Jeanne Koepsell
Journal:  Influenza Other Respir Viruses       Date:  2012-11-12       Impact factor: 4.380

Review 4.  Entry screening for infectious diseases in humans.

Authors:  Linda A Selvey; Catarina Antão; Robert Hall
Journal:  Emerg Infect Dis       Date:  2015-02       Impact factor: 6.883

5.  A model for the emergence of drug resistance in the presence of asymptomatic infections.

Authors:  Marguerite Robinson; Nikolaos I Stilianakis
Journal:  Math Biosci       Date:  2013-03-21       Impact factor: 2.144

6.  Revisiting the Effects of High-Speed Railway Transfers in the Early COVID-19 Cross-Province Transmission in Mainland China.

Authors:  Chun-Hsiang Chan; Tzai-Hung Wen
Journal:  Int J Environ Res Public Health       Date:  2021-06-13       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.